MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST001795/mwtabprimaryOK200Mass SpectrometryESIObesityhttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001795Treatment:HFDTreatment:Celecoxib_HFDTreatment:CFDMesenteric LymphReversed phase POSITIVE ION MODE. Reversed phase NEGATIVE ION MODE.MetabolomicsWorkbenchMetabolomicsMus MusculusMonash Institute of Pharmaceutical Sciences[PS(18:1)] 1-(9Z-octadecenoyl)-sn-glycero-3-phosphoserinePC 42:11[PA(20:4(5Z_8Z_11Z_14Z)/0:0)] 1-(5Z_8Z_11Z_14Z-eicosatetraenoyl)-sn-glycero-3-phosphateTremetonePA P-34:3 or PA O-34:4PC O-20:0PS(39:0)PS(38:3)FA hydroxy(18:1)MG(0:0/22:2(13Z_16Z)/0:0)Xestoaminol C1-eicosanoyl-(1-cyano-2-methylprop-2-en-1-ol)Tributyl phosphate4-DodecylphenolConiferyl alcoholFA oxo(21:0)ginsenoside Rh2PC O-32:0PS P-40:2 or PS O-40:3AltretaminePC P-36:3 or PC O-36:4GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)PE(40:8)Tetracosanoic acidPS(38:2)ThiocoralineN-(2-hydroxypentacosanoyl)-phytosphingosineFA hydroxy(18:0)bafilomycin A1Cer 35:0;O2SM 18:1;O2/24:0PE(O-20:0/0:0)PC 30:2PC 30:0PC 30:1SM 18:0;O2/16:0ubiquinol-1PS(39:2)PS(40:1)PS(38:5)CTABPG(17:0/14:1)TetrapentylammoniumErucicoyl-EA[PI(36:0)6-DeoxocastasteroneCer 18:0;O2/22:0PC 42:1PC 42:2PC 42:5TeasteronePC 42:4FA methyl(18:0)PC 42:9PS(39:1)FA hydroxy(18:2)PS(40:0)PC 42:7PC 42:814'-apo-beta-CarotenalPI(37:4)[FA methyl(18:0)] 9_10-methylene-9-octadecenoic acid[SP hydroxy_hydroxy_methyl(10:2/2:0)] 6R-(8-hydroxydecyl)-2R-(hydroxymethyl)-piperidin-3R-olOleamideN-(2-hydroxydocosanoyl)-sphinganinePC P-38:2 or PC O-38:3PA O-28:0PC P-38:4 or PC O-38:5PA P-30:0 or PA O-30:1CitratePS(41:0)PS(39:4)FA oxo(19:0)Cer 36:1;O2LPE 22:0LPE 22:1PI(38:4)Arachidyl palmitoleatePS(40:3)PC P-32:0 or PC O-32:1CAR 18:1PA P-32:1 or PA O-32:2PS(40:2)SpisulosineGlucosylceramide (d18:1/16:0)PS(39:3)LPC P-18:1 or LPC O-18:2PS(22:0/0:0)PS(38:6)[SP (3:0)] sphinga-4E_8E_10E-trienineLysoPE(20:1)PS(19:0/0:0)PI(38:3)PS 17:1PS O-16:0/22:1(11Z)*beta-EstradiolPA P-30:1 or PA O-30:21-Dodecanoyl-sn-glycerolSM 38:2;O2Retinaldi-n-Undecylamine[FA (18:2)] 3Z_13Z-octadecadien-1-olLPC 20:3LPC 20:4SM 40:2;O2PA P-34:2 or PA O-34:33alpha_7alpha_12alpha-Trihydroxy-5beta-cholestan-26-alLPC 20:1Cer 18:0;O2/24:0;OLPC 20:2SM 39:1;O2PI(P-33:1)LPC 20:0PE(30:0)Cer 40:1;O2PS(40:5)PS(18:0)PS(41:2)Tris(butoxyethyl)phosphateSM 38:1;O2Cyanidin 3-(6-acetylgalactoside)Cer(t18:0/h24:0)PC 40:3N-(11Z_14Z-eicosadienoyl)-ethanolaminePE(40:4)PC 40:4PC 40:1PC 40:2PC 40:7PC 40:8PC 40:5PS(41:1)PC 40:9FA oxo(18:0)PE(P-20:0)PS(39:5)Magnoshinin[ST Oxo(2:0)] 3-Oxochola-4_6-dien-24-oic AcidPE(30:1)PS(P-18:0/22:6(4Z_7Z_10Z_13Z_16Z_19Z))[SP dimethyl_amino(18:0/2:0)] 2S-dimethylaminooctadecane-1_3R-diolPI(38:5)PE(40:5)Phenylpyruvic acidPS P-36:0 or PS O-36:1PS(P-20:0/22:2(13Z_16Z))[FA hydroxy(20:4)] eicosatetraenoyl aminePI(34:3)1-18:0-2-18:3-monogalactosyldiacylglycerolPA 36:0LPE 20:2FA (17:0)SM 34:2;O2PS(41:4)LPE 20:0PG(36:4)GlucosylceramideFA (16:3)LPC 18:0LPC 18:1Pleuromutilinindole-3-acetyl-methionine4_8-Dimethyl-1_3E_7-nonatriene2-Aminotetradecanoic acidPI(34:2)CAR 16:0N-(2-hydroxy-docosanoyl)-pentadecasphing-4-enine-1-phosphoethanolaminePS(41:3)PS P-36:1 or PS O-36:2PG(36:3)FA (16:2)Cer 18:1;O2/16:0PC P-38:0 or PC O-38:1Cer 41:1;O2SM 34:1;O2PI(35:2)FA hydroxy(12:0) dodecanoic acidPS(41:6)GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)PS(42:3)PS(43:0)3_5_7-Trimethyl-2E_4E_6E_8E-decatetraenePA(18:2(9Z_12Z)/0:0)CAR 16:1;OHPG(36:2)3-Dimethylallyl-4-hydroxymandelic acid9_12-Hexadecadienoylcarnitine[ST] (5Z_7E)-9_10-seco-5_7_10(19)-cholestatriene[PS(20:4)] 1-(5Z_8Z_11Z_14Z-eicosatetraenoyl)-sn-glycero-3-phosphoserine[PG (16:0)] 1-hexadecanoyl-sn-glycero-3-phospho-(1'-sn-glycerol)MG(0:0/16:0/0:0)SM 36:2;O24-8dimethylnonanoylcarnitinePC(16:0/9:0(CHO))4Z_7Z_10Z_13Z_16Z_19Z_22Z_25Z-octacosaoctaenoic acidRetinol3_5_7-Trimethyl-2E_4E_6E_8E-undecatetraene1-O-Octadec-9-enyl glycerolPS(42:2)beta-TocotrienolPS(O-39:0)GlcCer 14:1;O2(4E)/20:0;OSM 18:2;O2/22:1anhydroretinolPE(P-42:6)DocosanamidePG(36:1)PS P-42:5 or PS O-42:6PC P-40:3 or PC O-40:4SP (4:0)[PI(18:0)] 1-octadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol)N-(2-hydroxytricosanoyl)-phytosphingosinePC P-38:1 or PC O-38:2HymenoflorinPE 40:7SM 36:1;O2BilirubinPE(36:5)PC 18:2PI(36:1)all-trans-13_14-DihydroretinolOctadecanoic acidPE 40:6PI(36:2)Margaroyl-EAPA 38:0PS(43:2)PA O-30:0PC O-34:0PE(17:0)MelampodininAntibiotic TAhaematoporphyrin IXCAR 14:1CAR 14:0FA methyl(16:1)3-Dehydro-2-deoxyecdysone2-heptaprenyl-3-methyl-6-methoxy-1_4-benzoquinolFA (14:2) tetradecadienalGlucosylceramide (d18:1/24:1(15Z))[PG (18:0)] 1-octadecanoyl-sn-glycero-3-phospho-(1'-sn-glycerol)PC P-34:0 or PC O-34:1[FA oxo(14:0)] 3-oxo-tetradecanoic acidPE(16:2)PA P-28:0 or PA O-28:1PS(33:0)SM(d18:0/24:1(15Z))Sphinganine(d17:0)ÊPE(38:1)Dodecanoic acidDocosanoic acidPI(36:4)PC P-36:4 or PC O-36:5PA 22:0/0:0*3-beta-Hydroxy-4-beta-methyl-5-alpha-cholest-7-ene-4-alpha-carboxylatealpha-Linolenoyl-EAPS(21:0/0:0)3-Ketosphingosine[FA (17:3)] 8Z_11Z_14Z-heptadecatrienoic acidRetinyl esterGanglioside GD3 (d18:0/14:0)[SP amino_dimethyl(18:0)] 2-amino-14_16-dimethyloctadecan-3-olN-(5-hydroxy-pentyl)-5Z_8Z_11Z_14Z-eicosatetraenoyl aminePS(O-41:0)Cer 18:0;O3/13:0;OPE(38:2)PI(36:3)PA 26:0FA(16:1)Tridecylic acidCer 33:1;O2Prosopinine16alpha-HydroxysteroidPA P-34:4 or PA O-34:5PC(o-22:0/20:4(8Z_11Z_14Z_17Z))Arachidonoyl-EA[PC(18:3)]PA 17:0/14:1*PG(34:1)(9S_10S)-10-Hydroxy-9-(phosphonooxy)octadecanoatePC P-22:3 or PC O-22:4[PI(18:1)] 1-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)FA oxo(15:0)PI(32:1)PE 42:65beta-cholestan-3alpha_4alpha_11beta_12beta_21-pentol-3_21-disulphateFA hydroxy (18:2)SM 42:3;O27_10_13_16-DocosatetraenoylethanolaminePE 42:3N-(octadecanoyl)-1-beta-glucosyl-pentadecasphing-4-eninePE 42:4PS(43:6)FA (20:2)3Z_6Z_9Z-TricosatrienePA O-32:0PS(43:21)3-O-(6'-O-(9Z_12Z_15Z-octadecatrienoyl)-beta-D-glucopyranosyl)-campest-5-en-3beta-olPG(34:0)[SP] Sphing-4-enine-1-phosphateCer 18:1;O2/24:1LPC 14:0FalcarindiolPC 28:0FA (20:3)LPC 16:1(9Z)*Cer 18:1;O2/24:0PS(P-39:1)N-(octadecanoyl)-1-beta-glucosyl-4E_6E-pentadecasphingadieninePA 44:6FA dimethyl(20:3)SM 33:1;O2PS 34:0FA (18:4)DihydroceramideFA (19:1)PA 44:1DecosideHexadecanoic acid[FA (16:2)] N-hexadecyl-ethanolaminePC 38:2PC 38:114:4(2E_4E_8E_10E)(6Me[S]_9Me_12Me[S])PC 38:4Stylisterol BPC 38:5FA (20:0)PS(44:5)PS(P-39:0)LinoleamideCer 33:0;O2DocosahexaenoicacidFA oxo(14:2) cyclopentanebutanoic acidCholestenoneFA (20:1)GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d34:1))N-(2-hydroxyicosanoyl)-phytosphingosinePC P-40:1 or PC O-40:2[FA (17:1)] 7-heptadecynoic acidPS(35:0)Cer 18:0;O2/16:03-O-(6'-O-(11Z_14Z_17Z-eicosatrienoyl)-beta-D-glucopyranosyl)-campest-5-en-3beta-olFA (18:1)FA methyl(14:0)PhytosphingosinePS O-18:0PA O-34:0SM(d18:1/24:1(15Z))PA 34:0PE(O-42:4)PS(20:0/0:0)PS P-38:2 or PS O-38:3(4Z_7Z_10Z_13Z_16Z_19Z)-Docosahexaenoic acid ethyl esterLPC 16:0HimbacinePC P-34:1SM 41:1;O2N-Acetyl-beta-glucosaminylamineGlucosylceramide (d18:1/22:0)8-hydroxy-13Z-octadecene-9_11-diynoic acid[SP hydroxy(16:0)] N-(hexadecanoyl)-4S-hydroxysphinganinePC 36:0PC 36:1PC 36:4Cer 18:0;O3/15:0;O[ST (3:0)] cholest-5Z_7Z_24-trien-3beta-olPC 36:5PC 36:2PC 36:31-(14-methyl-pentadecanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerolPI(34:1)PS(O-16:0/21:0)Sapelin Asoyasapogenol B-22-O-beta-glucosidePC(21:0(COOH))PS(O-37:1)Noladin EtherFA (18:3)SM 32:1;O2N-(2-hydroxyeicosanoyl)-sphinganinePS(35:1)Cer 41:0;O2PE(36:0)PI(34:0)Patellamide AOctadecadienal[FA (26:0)] hexacosanoic acidFA (18:2)PC P-40:2 or PC O-40:310_11-Dihydro-12R-hydroxy-leukotriene E4[ST hydroxy(2:0)] (5Z_7E)-(1R_2R_3R)-2-(5-hydroxypentoxy)-9_10-seco-5_7_10(19)-cholestatriene-1_3-diol[PE(O-18:2)] 1-octadecyl-sn-glycero-3-phosphoethanolaminePS(36:1)FA (23:1)FA oxo(14:1) cyclopentanebutanoic acidFA (14:1) tetradecenoic acidMG 14:0StearamidePE(P-20:0/22:4(7Z_10Z_13Z_16Z))LysoPE(20:5)CholesterolsulfatePC 24:0Avermectin B2b monosaccharidePS(36:0)PS P-38:1 or PS O-38:2FA hydroxy(20:4)[FA oxo(16:2)] cyclopentanehexanoic acidPE(34:0)CGS 7181[GL (18:0/20:4)] 1-(9Z-octadecenoyl)-2-(5Z_8Z_11Z_14Z-eicosatetraenoyl)-3-O-alpha-D-glucuronyl-sn-glycerolHomophytanicacidFA (22:5)PA 40:1PA 40:3N-(2-hydroxyoctadecanoyl)-phytosphingosineN_N-Dimethylsphing-4-enineMG(0:0/22:4(7Z_10Z_13Z_16Z)/0:0)(1R_4S)-fenchan-2-onePC 34:2PS(36:3)PC 34:3LPC 22:5PC 34:0PS(37:0)PC 34:1Ganglioside GM3 (d18:0/16:0)PC 34:4LPC 22:0[PI(20:4)] 1-(5Z_8Z_11Z_14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)PhencyclidinePA(18:1(9Z)/0:0)TridemorphSM(d17:1/24:1(15Z))16-feruloyloxypalmitatePC P-42:4 or PC O-42:5N-(2-hydroxynonadecanoyl)-phytosphingosine[FA (24:0)] 15Z-tetracosenoic acidFA hydroxy(22:0)PI(18:2)Tritriacontane-16_18-dioneEstradiol-17-phenylpropionate1_2-di-S-octyl-1_2-dimercapto-3-propanolPI(40:4)PA P-34:1 or PA O-34:2PS(37:2)PS P-29:0 or PS O-29:1FA hydroxy(20:1)HexadecenalEicosanoyl-EADG 42:91-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5'- diphosphateTG(12:0/12:0/12:0)PC P-36:1 or PC O-36:2SM 40:1;O2PI(40:7)[SP] (3'-sulfo)Galbeta-Cer(d18:0/2-OH-18:0)Proscillaridin AMinabeolide-2N-(2-hydroxyundecanoyl)-phytosphingosinePA 30:3SM 35:1;O2LPC 12:0PS(37:1)PC 22:1LPC 24:1(15Z)*PS(36:4)FA (22:1)[ST hydroxy(4:0)] 1beta_3alpha_7alpha_12alpha-Tetrahydroxy-5beta-cholan-24-oic AcidPC(21:0(CHO))PE(32:1)N-(2-hydroxy-tetracosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamineN-(2-hydroxyoctadecanoyl)-sphinganinePA 42:1[SP amino_trihydroxy_hydroxy_methyl_oxo(20:0)] 2S-amino-3R_4R_5S-trihydroxy-2-(hydroxymethyl)-14-oxo-eicos-6E-enoic acidFA hydroxy(18:1)]PC 32:0PC 32:1PA P-34:0 or PA O-34:1LPC 24:0FA hydroxy(20:3)PS(38:1)[SP methyl(2:0)] 9-methyl-sphinga-4E_8E-dieninePC 32:2PC 32:3[FA (34:2)] 1-octadecyl-11E-hexadecenoate[PI(16:0)] 1-hexadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol)PS(P-20:0/21:0)CDP-DG(36:2)[FA (22:4)] 7Z_10Z_13Z_16Z-docosatetraenoic acidFA (20:4)PA 42:10acyl phosphatidylglycerol (n-C12:0)[PC(22:6/22:6)] 1_2-di-(4Z_7Z_10Z_13Z_16Z_19Z-docosahexaenoyl)-sn-glycero-3-phosphocholinePC P-36:0 or PC O-36:1BurseranLysoPE(22:5)Aeruginopeptin 917S-CCer 18:0;O2/24:0PG(32:0)[ST methy] 24-methylene-cholest-5-en-3beta-ol-3-sulfatePS(38:0)PS(37:3)[PE(16:1)] 1-(1Z-hexadecenyl)-sn-glycero-3-phosphoethanolaminePC P-40:0 or PC O-40:1LPE 16:0lipids, 3.4.22.-, SCARB3, Food Patterns, BODYFAT, CT11259, Laboratory, Mus domesticus, GPIIIB, mini-ICE, CASP-14, l(2)ft, fat, hFat1, BDPLT10, Dm Fat, House Mouse, Patterns, SC 58635, CDHF7, House, PAS-4, Diets, Mus musculus domesticus, Scarb3, Celebrex, CG3352, Cph1, GP3B, Mice, fat tissue, celecoxib, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide, Food Pattern, adipose system, Swiss, Swiss Mice, 79/18, CG1945, Fatty acid translocase, Food, Pattern, GP4, Glycoprotein IIIb, bodyfat, Dietary Pattern, CPH, DmelCG3352, l(2)gd-1, BcDNA:LD22582, R74677, CASP14, mouse, p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide, BcDNA.LD22582, l(2)gd2, Lymphs, CD36, ME5, celecoxibum., Body Fat, Platelet glycoprotein IV, PASIV, Mus, Lipid, Mini-ICE, PAS IV, SC58635, Cph-1, l(2)k07918, CDHR8, Platelet collagen receptor, Mus musculus, Leukocyte differentiation antigen CD36, Caspase-14 subunit p10, SC-58635, mice, lympha, Dietary, Swiss Mouse, CHDS7, l(2)gd-l, House Mice, Caspase-14 subunit p19, MICE, Laboratory Mice, domesticus, l(2)fd, Dietary Patterns, fatty depot, adipose, Faf, DmelCG1945, Ft, Thrombospondin receptor, l(2)fat, l(2)24Da, Mouse, GPIV, Fat, FAT, Laboratory Mouse, l(2)79/18backward, reversed., reversedfalseChanges in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I)ST00179510090